Second campaign to promote the colon cancer screening programme through swiss community pharmacies

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: BESANCON, Luc (pharmaSuisse, Innovation and International)
  • Co-author(s): Daniela Stebler: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Andrea Brügger: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Martine Ruggli: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Luc Besançon: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
    Fabian Vaucher: pharmaSuisse, Bern-Liebefeld, Switzerland
  • Abstract:

    Background

    In Switzerland, 4300 new patients are diagnosed every year with colon cancer, leading to 1700 deaths. Early detection is therefore key.

    Methods

    pharmaSuisse has developed a service integrating stool test for early detection of colon cancer. Patients are first screened. If no red flags are detected, they receive the stool test as well as

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login

FIP links